143 related articles for article (PubMed ID: 35172317)
21. Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.
Li X; Li Y; Cao Y; Li P; Liang B; Sun J; Feng E
Int J Neurosci; 2017 Nov; 127(11):1005-1011. PubMed ID: 28288541
[TBL] [Abstract][Full Text] [Related]
22. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.
Scott JN; Rewcastle NB; Brasher PM; Fulton D; MacKinnon JA; Hamilton M; Cairncross JG; Forsyth P
Ann Neurol; 1999 Aug; 46(2):183-8. PubMed ID: 10443883
[TBL] [Abstract][Full Text] [Related]
23. The effect of race on the prognosis of the glioblastoma patient: a brief review.
Patel NP; Lyon KA; Huang JH
Neurol Res; 2019 Nov; 41(11):967-971. PubMed ID: 31271539
[No Abstract] [Full Text] [Related]
24. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
[TBL] [Abstract][Full Text] [Related]
25. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
Zhu P; Du XL; Lu G; Zhu JJ
Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
[TBL] [Abstract][Full Text] [Related]
26. The clinical characteristics and prognostic factors of multiple lesions in glioblastomas.
Tunthanathip T; Sangkhathat S; Tanvejsilp P; Kanjanapradit K
Clin Neurol Neurosurg; 2020 Aug; 195():105891. PubMed ID: 32480195
[TBL] [Abstract][Full Text] [Related]
27. Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.
Bin Abdulrahman AK; Bin Abdulrahman KA; Bukhari YR; Faqihi AM; Ruiz JG
Brain Behav; 2019 Oct; 9(10):e01402. PubMed ID: 31464386
[TBL] [Abstract][Full Text] [Related]
28. Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review.
Yang R; Isaacs AM; Cadieux M; Hirmer TJ; CreveCoeur TS; Lapointe AP; Opoku-Darko M; Premji Z; Riva-Cambrin J; Gallagher CN
Childs Nerv Syst; 2021 Jun; 37(6):1849-1858. PubMed ID: 33675391
[TBL] [Abstract][Full Text] [Related]
29. Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme.
Kamiryo T; Tada K; Shiraishi S; Shinojima N; Nakamura H; Kochi M; Kuratsu J; Saya H; Ushio Y
J Neurosurg; 2002 May; 96(5):815-22. PubMed ID: 12005388
[TBL] [Abstract][Full Text] [Related]
30. Deep Learning Approaches for Glioblastoma Prognosis in Resource-Limited Settings: A Study Using Basic Patient Demographic, Clinical, and Surgical Inputs.
Ghanem M; Ghaith AK; Zamanian C; Bon-Nieves A; Bhandarkar A; Bydon M; Quiñones-Hinojosa A
World Neurosurg; 2023 Jul; 175():e1089-e1109. PubMed ID: 37088416
[TBL] [Abstract][Full Text] [Related]
31. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
Barami K; Lyon L; Conell C
World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
[TBL] [Abstract][Full Text] [Related]
32. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
Pan IW; Ferguson SD; Lam S
J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
[TBL] [Abstract][Full Text] [Related]
33. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
[TBL] [Abstract][Full Text] [Related]
34. Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study.
Nelson JS; Burchfiel CM; Fekedulegn D; Andrew ME
J Neurooncol; 2012 Sep; 109(2):315-21. PubMed ID: 22588335
[TBL] [Abstract][Full Text] [Related]
35. Incidence of metastatic disease and survival among patients with newly diagnosed primary CNS tumors in the United States from 2004-2013.
Lian H; Daniels C; Han YP; Li QF; Zhao Y; Wang BC; Zhu CB; Mao WW; Taylor MD; Ma J
J Cancer; 2019; 10(13):3037-3045. PubMed ID: 31281481
[No Abstract] [Full Text] [Related]
36. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
37. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
38. Pathological and clinical features of cystic and noncystic glioblastomas.
Utsuki S; Oka H; Suzuki S; Shimizu S; Tanizaki Y; Kondo K; Tanaka S; Kawano N; Fujii K
Brain Tumor Pathol; 2006 Apr; 23(1):29-34. PubMed ID: 18095116
[TBL] [Abstract][Full Text] [Related]
39. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
40. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
